子宫动脉结扎术联合水囊压迫治疗前置胎盘剖宫产术中及产后出血的应用分析  

Application analysis of uterine artery ligation combined with water sac compression in treating hemorrhage during cesarean section of placenta previa and postpartum hemorrhage

作　　者：孙茹欣[1] 王煜[1] 

机构地区：[1]沈阳市妇婴医院妇产科,辽宁沈阳110013

出　　处：《中国计划生育和妇产科》2016年第1期65-67,共3页Chinese Journal of Family Planning & Gynecotokology

摘　　要：目的探讨子宫动脉结扎术联合水囊压迫治疗前置胎盘剖宫产术中及产后出血的临床价值。方法回顾性分析2014年10月至2015年8月沈阳市妇婴医院收治的前置胎盘行剖宫产术术中及产后出血50例患者的临床资料,其中观察组25例行子宫动脉结扎术联合水囊压迫治疗,对照组25例采用宫腔填塞纱布止血,两组均使用缩宫药物治疗,比较两组患者疗效及术后并发症情况。结果观察组术中出血量[(1 098±104.4)m L]、手术时间[(50±14.5)min]、子宫切除率(0)及产后发热率(8.0%)均少于对照组[(1 207±198.6)m L、(65±17.2)min、(24.0%)、(32.0%)],差异有统计学意义(P<0.05);两组宫腔粘连及月经改变情况比较差异无统计学意义(P>0.05)。结论子宫动脉结扎术联合水囊压迫治疗前置胎盘导致的产后出血疗效显著,方便可行,值得推广。Objective To explore the clinical practical value of treatment of uterine artery ligation combined water sac compression in homorrhage during cesarean section of placenta previa and postpartum hemorrhage. Methods Retrospectively analyzed clinical data of 50 cases with hemorrhage during cesation section of placenta previa and postpartum hemorrhage treated in Women and Children＇s Hospital of Shenyang City from October 2014 to August 2015 ,in which 25 cases treated with uterine artery ligation combined water sac compression were chosen as the observation group, another 25 cases with filling gauze in the uterus to stop bleeding were chosen as the control group, both groups were cured with uterotonic, compared curative effect and postoperative complications of the two groups. Results Blood loss, operative time, hysterectomy and postpartum fever in observation group were less than those of the control group, the differences were statistically significant （ P 〈 0. 05 ）, intrauterine adhesions and menstrual changes of two groups had no obvious difference （P 〉 0. 05）. Conclusion The uterine artery ligation combined water sac compression has obvious therapeutic effect in postpartum hemorrhage caused by placenta previa, and it is convenient and feasible,worth promoting.

关 键 词：子宫动脉结扎术 前置胎盘 产后出血 治疗 

分 类 号：R714.461[医药卫生—妇产科学]